Search for a rare disease
Other search option(s)
Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency
Disease definition
A rare form of congenital diazoxide-sensitive diffuse hyperinsulinism due to short chain 3 hydroxylacyl-CoA dehydrogenase (SCHAD; HADH gene) deficiency and characterized by hyperinsulinemic hypoglycemia with seizures and reported to respond well to diazoxide. It presents with the classical manifestations of hyperinsulinemic hypoglycemia. Exceptional complications include sudden death, and in one case fulminant hepatic failure.
ORPHA:71212
Classification level: Disorder- Synonym(s):
- Hyperinsulinemic hypoglycemia due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency
- Hyperinsulinism due to SCHAD deficiency
- Hyperinsulinism due to glutamodehydrogenase deficiency
- SCHAD deficiency
- Prevalence: <1 / 1 000 000
- Inheritance: Autosomal recessive
- Age of onset: Infancy, Neonatal
- ICD-10: E71.3
- OMIM: 231530 609975
- UMLS: C1291230
- MeSH: -
- GARD: 2819 9870
- MedDRA: -
A summary on this disease is available in Español (2022) Français (2022) Nederlands (2022) Deutsch (2014) Italiano (2014) Polski (2014) Polski ()
Detailed information
Guidelines
- Clinical practice guidelines
- Français (2021) - PNDS
Disease review articles
- Review article
- English (2011) - Orphanet J Rare Dis


Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Specialised Social Services
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.